Who We are

Cellix is an innovative drug design and development Biopharmaceutical Company founded on May 21, 2014 is focused to develop best-in-class therapies for the treatment of Neurological, Inflammatory and Metabolic Diseases. Using our proprietary technologies and strong scientific platform “Synergix”; new and effective medicines are being developed that modulate more than one target in the disease pathway while minimizing as much risk as possible from the discovery and development process. We select drugs known for their demonstrated efficacy and clinical safety along the targeted biological pathway, and use our proprietary synergix technology platform to produce new medicines that modulate the disease pathway with enhanced safety and efficacy profile.


Our Science Team